You are not currently logged in.
Access JSTOR through your library or other institution:
Price Inferences for Sacred versus Secular Goods: Changing the Price of Medicine Influences Perceived Health Risk
Adriana Samper and Janet A. Schwartz
Journal of Consumer Research
Vol. 39, No. 6 (April 2013), pp. 1343-1358
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/10.1086/668639
Page Count: 16
You can always find the topics here!Topics: Prices, Consumer prices, Vaccination, Disease risk, Market prices, Public health, Cream, Skin cancers, Emotion, Financial risk
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
The current research examines how the price of a medication influences consumers’ beliefs about their own disease risk—a critical question with new laws mandating greater price transparency for health care goods and services. Four studies reveal that consumers believe that lifesaving health goods are priced according to perceived need (i.e., communal-sharing principles) and that price consequently influences risk perceptions and intentions to consume care. Specifically, consumers believe that lower medication prices signal greater accessibility to anyone in need, and such accessibility thus makes them feel that their own self-risk is elevated, increasing consumption. The reverse is true for higher prices. Importantly, these effects are limited to self-relevant health threats and reveal that consumers make inconsistent assumptions about risk, prevalence, and need with price exposure. These findings suggest that while greater price transparency may indeed reduce consumption of higher-priced goods, it may do so for both necessary and unnecessary care.
© 2012 by JOURNAL OF CONSUMER RESEARCH, Inc.